Filter announcements
Loading...
Incorporated in 2016, Vasa Denticity Limited is in the business of marketing and distributionof a comprehensive portfolio of Dental Products.
Vasa Denticity allotted 1.50 lakh equity shares to Malabar India Fund at Rs. 578/share, completing warrant conversion. This final tranche concludes the 8.65 lakh warrant conversion, raising a total of Rs. 50 Cr and increasing Malabar's stake to 6.43%.
Vasa Denticity mutually called off the IDS Denmed acquisition due to differing business maturities and complex integration. There's no financial impact. The company will now focus on strengthening its core dentalkart.com business and organic growth for FY27, prioritizing operating efficiency over inorganic expansion.
Vasa Denticity, an NSE SME Emerge listed company, confirms it is not required to submit the Annual Secretarial Compliance Report for FY2026. This streamlines its compliance, aligning with its SME status.
Vasa Denticity allotted 6,751 new equity shares under its ESOP scheme, slightly increasing paid-up capital from ₹17.33 Cr to ₹17.34 Cr. The company received ₹67,510 from these exercised options. EPS impact is negligible.
Vasa Denticity's growth slowed to 13% and PAT declined, citing tender business cuts, BOE-BOD shift, and private label stock-outs. Management targets 25-30% revenue growth, high 20s% gross margin, and mid-teens% EBITDA in 2-3 years. Inventory is elevated; IDS Denmed acquisition pending.